CD19 LYMPHOCYTES INCREASED

This adverse event was reported 17 times

These drugs are most commonly taken by patients reporting CD19 LYMPHOCYTES INCREASED:

# Drug Count
0 OCRELIZUMAB 5
1 RITUXIMAB 4
2 GABAPENTIN 2
3 OFATUMUMAB 2
4 ACETAMINOPHEN 1
5 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 1
6 BIOTIN 1
7 BREXUCABTAGENE AUTOLEUCEL 1
8 CALCIUM 1
9 CLADRIBINE 1
See all common drugs associated with CD19 LYMPHOCYTES INCREASED

CD19 LYMPHOCYTES INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BREXUCABTAGENE AUTOLEUCEL 1 0.0005
1 NORGESTIMATE AND ETHINYL ESTRADIOL 1 0.0002
2 VOCLOSPORIN 1 0.0001
3 CLADRIBINE 1 0.0001
4 DIROXIMEL FUMARATE 1 0.0001
5 OCRELIZUMAB 5 0.0001
6 OFATUMUMAB 2 0.0001
7 TIZANIDINE 1 0.0000
8 BIOTIN 1 0.0000
9 LISDEXAMFETAMINE DIMESYLATE 1 0.0000
See all drugs enriched for association with CD19 LYMPHOCYTES INCREASED

CD19 LYMPHOCYTES INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD20-directed Cytolytic Antibody [EPC] 10 0.0000
1 Potassium Channel Blocker [EPC] 1 0.0000
2 Arteriolar Vasodilator [EPC] 1 0.0000
3 Purine Antimetabolite [EPC] 1 0.0000
4 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
5 Calcium [EPC] 1 0.0000
6 Expectorant [EPC] 1 0.0000
7 Thiazide Diuretic [EPC] 1 0.0000
8 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
9 Vitamin C [EPC] 1 0.0000
See all drug classes enriched for association with CD19 LYMPHOCYTES INCREASED